Published on

Participation in Brain Innovation Days

A new technology called SonoCloud uses low ultrasonic energy to stimulate microbubbles that stretch capillary walls and create a temporary opening in the brain blood barrier. A first-in-human trial of the technology has shown that it can be used to give a chemotherapy drug to glioblastoma patients, and that it appeared to improve the effectiveness of treatment.
Visit the Brain Innovation Days website: